When markets get choppy, dividend stocks like AbbVie and Merck offer steady anchors. Despite patent challenges, both pharma giants are powering ahead: AbbVie’s new drugs and potential weight-loss therapy are building momentum, while Merck’s Keytruda and next-gen cancer treatments keep revenue flowing. Solid pipelines, but always do your homework before investing.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/351ffbb3ded9eefa

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av, eller tillsammans med, Poddtoppen.